CPIC Genes/Drugs

CPIC guidelines are designed to help clinicians understand HOW available genetic test results should be used to optimize drug therapy, rather than WHETHER tests should be ordered. A key assumption underlying the CPIC guidelines is that clinical high-throughput and pre-emptive (pre-prescription) genotyping will become more widespread, and that clinicians will be faced with having patients' genotypes available even if they have not explicitly ordered a test with a specific drug in mind. CPIC invites feedback on existing and planned gene/drug guidelines.

View CPIC's process for prioritizing genes/drugs
View CPIC's levels for genes/drugs